Shares in Roche dropped more than 5% on March 9 after the Swiss pharmaceutical company announced that its experimental oral breast cancer drug giredestrant failed to show effectiveness in newly diagnosed patients.
British pharmaceutical giant AstraZeneca announced a sharp rise in quarterly profit on Thursday, driven by strong sales of cancer treatments and growth in its U.S. business.
Pfizer and 3SBio have finalized a licensing agreement that grants the US pharmaceutical giant worldwide rights to sell the Hong Kong-listed firm's cancer drug, marking the largest deal ever for a single drug in China’s biotech industry.
09 Mar 2026-13:54
06 Nov 2025-17:53
